Ray Dalio's INDV Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 68,181 shares of Indivior Pharmaceuticals, Inc. (INDV) worth $2.8 M, representing 0.01% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in INDV, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 31,040 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Indivior Pharmaceuticals (INDV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Indivior Pharmaceuticals (INDV) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +31,040 | Add 83.57% | 68,181 | $41.03 |
| Q1 2026 | +37,141 | New Buy | 37,141 | $30.48 |
Ray Dalio's Indivior Pharmaceuticals Investment FAQs
Ray Dalio first purchased Indivior Pharmaceuticals, Inc. (INDV) in Q1 2026, acquiring 37,141 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Indivior Pharmaceuticals, Inc. (INDV) for 2 quarters since Q1 2026.
Ray Dalio's largest addition to Indivior Pharmaceuticals, Inc. (INDV) was in Q1 2026, adding 37,141 shares worth $1.13 M.
According to the latest 13F filing for Q2 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 68,181 shares of Indivior Pharmaceuticals, Inc. (INDV), valued at approximately $2.8 M.
As of the Q2 2026 filing, Indivior Pharmaceuticals, Inc. (INDV) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Indivior Pharmaceuticals, Inc. (INDV) was 68,181 shares, as reported at the end of Q2 2026.